WASHINGTON, DC, March 5, 2024 – In an effort to advance the understanding and treatment of degenerated bioprosthetic aortic valve disease, a groundbreaking multicenter clinical trial has been announced by Principal Investigator Ron Waksman, MD, on the eve of the Cardiovascular Research Technologies (CRT) 2024 conference, seeking site enrollment across the nation.